{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:54:45Z","timestamp":1794293685568,"version":"4.9.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Mucosal healing (MH) is an important goal in the treatment of patients with Crohn\u2019s disease (CD). Noninvasive assessment of MH with normalized iodine concentration (NIC) is unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this retrospective study, 94 patients with diagnosed CD underwent endoscopy and dual-energy CT enterography (DECTE) at the post-infliximab treatment review. Two radiologists reviewed DECTE images by consensus for assessing diseased bowel segments of the colon or terminal ileum, and the NIC was measured. Patients were divided into transmural healing (TH), MH and non-MH groups. The diagnostic performance of the MH and non-MH groups with clinical factors and NIC was assessed utilizing receiver operating characteristic (ROC) curve analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 94 patients included in our study, 8 patients achieved TH, 34 patients achieved MH, and 52 patients did not achieve MH at the post-IFX treatment review. The area under the ROC curve (AUC), sensitivity, specificity, and accuracy values were 0.929 (95% confidence interval [CI] 0.883\u20130.967), 0.853, 0.827, and 0.837, respectively, for differentiating MHs from non-MHs, and the optimal NIC threshold was 0.448. The AUC of the combined model for distinguishing MHs from non-MHs in CD patients, which was based on the NIC and calprotectin, was 0.964 (95% CI 0.935\u20130.987).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The normalized iodine concentration measurement in DECTE has good performance in assessment MH in patients with CD. Iodine concentration from DECTE can be used as a radiologic marker for MH.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13244-023-01397-7","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T10:08:14Z","timestamp":1681380494000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mucosal healing assessment in Crohn\u2019s disease with normalized iodine concentration from dual-energy CT enterography: comparison with endoscopy"],"prefix":"10.1186","volume":"14","author":[{"given":"Chao","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yankun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"1397_CR1","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"D Turner","year":"2021","unstructured":"Turner D, Ricciuto A, Lewis A et al (2021) STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 160:1570\u20131583","journal-title":"Gastroenterology"},{"key":"1397_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S2468-1253(19)30088-3","volume":"4","author":"S Ben-Horin","year":"2019","unstructured":"Ben-Horin S, Lahat A, Amitai MM et al (2019) Assessment of small bowel mucosal healing by video capsule endoscopy for the prediction of short-term and long-term risk of Crohn\u2019s disease flare: a prospective cohort study. Lancet Gastroenterol Hepatol 4:519\u2013528","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1397_CR3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/apt.15870","volume":"52","author":"L Bertani","year":"2020","unstructured":"Bertani L, Fornai M, Fornili M et al (2020) Serum oncostatin M at baseline predicts mucosal healing in Crohn\u2019s disease patients treated with infliximab. Aliment Pharmacol Ther 52:284\u2013291","journal-title":"Aliment Pharmacol Ther"},{"key":"1397_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S2468-1253(21)00096-0","volume":"6","author":"S Geyl","year":"2021","unstructured":"Geyl S, Guillo L, Laurent V, D\u2019Amico F, Danese S, Peyrin-Biroulet L (2021) Transmural healing as a therapeutic goal in Crohn\u2019s disease: a systematic review. Lancet Gastroenterol Hepatol 6:659\u2013667","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1397_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1053\/j.gastro.2020.03.039","volume":"159","author":"RC Ungaro","year":"2020","unstructured":"Ungaro RC, Yzet C, Bossuyt P et al (2020) Deep remission at 1 year prevents progression of early Crohn\u2019s disease. Gastroenterology 159:139\u2013147","journal-title":"Gastroenterology"},{"key":"1397_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/apt.16892","volume":"56","author":"R Vaughan","year":"2022","unstructured":"Vaughan R, Tjandra D, Patwardhan A et al (2022) Toward transmural healing: sonographic healing is associated with improved long-term outcomes in patients with Crohn\u2019s disease. Aliment Pharmacol Ther 56:84\u201394","journal-title":"Aliment Pharmacol Ther"},{"key":"1397_CR7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/apt.16232","volume":"53","author":"P Lafeuille","year":"2021","unstructured":"Lafeuille P, Hordonneau C, Vignette J et al (2021) Transmural healing and MRI healing are associated with lower risk of bowel damage progression than endoscopic mucosal healing in Crohn\u2019s disease. Aliment Pharmacol Ther 53:577\u2013586","journal-title":"Aliment Pharmacol Ther"},{"key":"1397_CR8","doi-asserted-by":"publisher","first-page":"6628","DOI":"10.1007\/s00330-022-08989-9","volume":"32","author":"C Zhu","year":"2022","unstructured":"Zhu C, Hu J, Wang X et al (2022) A novel clinical radiomics nomogram at baseline to predict mucosal healing in Crohn\u2019s disease patients treated with infliximab. Eur Radiol 32:6628\u20136636","journal-title":"Eur Radiol"},{"key":"1397_CR9","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.cgh.2012.03.026","volume":"10","author":"S Samuel","year":"2012","unstructured":"Samuel S, Bruining DH, Loftus EV Jr et al (2012) Endoscopic skipping of the distal terminal ileum in Crohn\u2019s disease can lead to negative results from ileocolonoscopy. Clin Gastroenterol Hepatol 10:1253\u20131259","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1397_CR10","doi-asserted-by":"publisher","first-page":"e00135","DOI":"10.14309\/ctg.0000000000000135","volume":"11","author":"X Lin","year":"2020","unstructured":"Lin X, Qiu Y, Feng R et al (2020) Normalization of C-reactive protein predicts better outcome in patients With Crohn\u2019s disease with mucosal healing and deep remission. Clin Transl Gastroenterol 11:e00135","journal-title":"Clin Transl Gastroenterol"},{"key":"1397_CR11","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1148\/radiol.2018171737","volume":"286","author":"DH Bruining","year":"2018","unstructured":"Bruining DH, Zimmermann EM, Loftus EV Jr, Sandborn WJ, Sauer CG, Strong SA (2018) Consensus recommendations for evaluation, interpretation, and utilization of computed tomography and magnetic resonance enterography in patients with small Bowel Crohn\u2019s disease. Radiology 286:776\u2013799","journal-title":"Radiology"},{"key":"1397_CR12","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.2214\/AJR.15.15256","volume":"206","author":"C Kim","year":"2016","unstructured":"Kim C, Park SH, Yang SK et al (2016) Endoscopic complete remission of crohn disease after anti-tumor necrosis factor-\u03b1 therapy: CT enterographic findings and their clinical implications. AJR Am J Roentgenol 206:1208\u20131216","journal-title":"AJR Am J Roentgenol"},{"key":"1397_CR13","doi-asserted-by":"publisher","first-page":"110469","DOI":"10.1016\/j.ejrad.2022.110469","volume":"155","author":"MC Kim","year":"2022","unstructured":"Kim MC, Kim SH, Koh SJ, Park JH, Yoon H (2022) Clinical implication of radiologic complete remission on Crohn\u2019s disease: compared with endoscopic remission. Eur J Radiol 155:110469","journal-title":"Eur J Radiol"},{"key":"1397_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1148\/radiol.2015151560","volume":"280","author":"S Gordic","year":"2016","unstructured":"Gordic S, Puippe GD, Krauss B et al (2016) Correlation between dual-energy and perfusion CT in patients with hepatocellular carcinoma. Radiology 280:78\u201387","journal-title":"Radiology"},{"key":"1397_CR15","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1007\/s00330-015-4154-9","volume":"26","author":"WM Thaiss","year":"2016","unstructured":"Thaiss WM, Haberland U, Kaufmann S et al (2016) Iodine concentration as a perfusion surrogate marker in oncology: further elucidation of the underlying mechanisms using Volume Perfusion CT with 80 kVp. Eur Radiol 26:2929\u20132936","journal-title":"Eur Radiol"},{"key":"1397_CR16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1148\/radiol.2021204405","volume":"301","author":"B Dane","year":"2021","unstructured":"Dane B, Sarkar S, Nazarian M et al (2021) Crohn disease active inflammation assessment with iodine density from dual-energy CT enterography: comparison with histopathologic analysis. Radiology 301:144\u2013151","journal-title":"Radiology"},{"key":"1397_CR17","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3348\/kjr.2018.19.6.1077","volume":"19","author":"YS Kim","year":"2018","unstructured":"Kim YS, Kim SH, Ryu HS, Han JK (2018) Iodine quantification on spectral detector-based dual-energy CT enterography: correlation with Crohn\u2019s disease activity index and external validation. Korean J Radiol 19:1077\u20131088","journal-title":"Korean J Radiol"},{"key":"1397_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","volume":"13","author":"C Maaser","year":"2019","unstructured":"Maaser C, Sturm A, Vavricka SR et al (2019) ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis 13:144\u2013164","journal-title":"J Crohns Colitis"},{"key":"1397_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/gutjnl-2013-304984","volume":"63","author":"L Peyrin-Biroulet","year":"2014","unstructured":"Peyrin-Biroulet L, Reinisch W, Colombel JF et al (2014) Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn\u2019s disease in the SONIC trial. Gut 63:88\u201395","journal-title":"Gut"},{"key":"1397_CR20","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.cgh.2018.01.024","volume":"16","author":"I Weinstein-Nakar","year":"2018","unstructured":"Weinstein-Nakar I, Focht G, Church P et al (2018) Associations among mucosal and transmural healing and fecal level of calprotectin in children with Crohn\u2019s disease. Clin Gastroenterol Hepatol 16:1089-1097.e1084","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1397_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","volume":"60","author":"M Daperno","year":"2004","unstructured":"Daperno M, D\u2019Haens G, Van Assche G et al (2004) Development and validation of a new, simplified endoscopic activity score for Crohn\u2019s disease: the SES-CD. Gastrointest Endosc 60:505\u2013512","journal-title":"Gastrointest Endosc"},{"key":"1397_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-022-01288-9","author":"X Xu","year":"2022","unstructured":"Xu X, Zhu J, Wang X, Zhu C, Wu X (2022) Diagnostic performance of dual-energy CT in nonspecific terminal ileitis. Jpn J Radiol. https:\/\/doi.org\/10.1007\/s11604-022-01288-9","journal-title":"Jpn J Radiol"},{"key":"1397_CR23","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/apt.15190","volume":"49","author":"F Castiglione","year":"2019","unstructured":"Castiglione F, Imperatore N, Testa A et al (2019) One-year clinical outcomes with biologics in Crohn\u2019s disease: transmural healing compared with mucosal or no healing. Aliment Pharmacol Ther 49:1026\u20131039","journal-title":"Aliment Pharmacol Ther"},{"key":"1397_CR24","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1007\/s00330-017-5215-z","volume":"28","author":"SM Lee","year":"2018","unstructured":"Lee SM, Kim SH, Ahn SJ, Kang HJ, Kang JH, Han JK (2018) Virtual monoenergetic dual-layer, dual-energy CT enterography: optimization of keV settings and its added value for Crohn\u2019s disease. Eur Radiol 28:2525\u20132534","journal-title":"Eur Radiol"},{"key":"1397_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11604-020-01065-6","volume":"39","author":"E Guler","year":"2021","unstructured":"Guler E, Unal NG, Hekimsoy I et al (2021) Dual-energy CT enterography in evaluation of Crohn\u2019s disease: the role of virtual monochromatic images. Jpn J Radiol 39:341\u2013348","journal-title":"Jpn J Radiol"},{"key":"1397_CR26","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1053\/j.gastro.2018.01.004","volume":"154","author":"G D'Haens","year":"2018","unstructured":"D\u2019Haens G, Vermeire S, Lambrecht G et al (2018) Increasing infliximab dose based on symptoms, biomarkers, and serum drug concentrations does not increase clinical, endoscopic, and corticosteroid-free remission in patients with active luminal Crohn\u2019s disease. Gastroenterology 154:1343-1351.e1341","journal-title":"Gastroenterology"},{"key":"1397_CR27","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.cgh.2019.05.029","volume":"18","author":"E Dreesen","year":"2020","unstructured":"Dreesen E, Baert F, Laharie D et al (2020) Monitoring a combination of calprotectin and infliximab identifies patients with mucosal healing of Crohn\u2019s disease. Clin Gastroenterol Hepatol 18:637-646.e611","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1397_CR28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.cgh.2020.03.066","volume":"19","author":"B Jessen","year":"2021","unstructured":"Jessen B, Rodriguez-Sillke Y, Sonnenberg E et al (2021) Level of tumor necrosis factor production by stimulated blood mononuclear cells can be used to predict response of patients with inflammatory bowel diseases to infliximab. Clin Gastroenterol Hepatol 19:721-731.e721","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1397_CR29","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1093\/ecco-jcc\/jjw075","volume":"10","author":"Z Grover","year":"2016","unstructured":"Grover Z, Burgess C, Muir R, Reilly C, Lewindon PJ (2016) Early mucosal healing with exclusive enteral nutrition is associated with improved outcomes in newly diagnosed children with luminal Crohn\u2019s disease. J Crohns Colitis 10:1159\u20131164","journal-title":"J Crohns Colitis"},{"key":"1397_CR30","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/ecco-jcc\/jjaa042","volume":"14","author":"SM Noh","year":"2020","unstructured":"Noh SM, Oh EH, Park SH et al (2020) Association of faecal calprotectin level and combined endoscopic and radiological healing in patients with Crohn\u2019s disease receiving anti-tumour necrosis factor therapy. J Crohns Colitis 14:1231\u20131240","journal-title":"J Crohns Colitis"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-023-01397-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-023-01397-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-023-01397-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T16:53:01Z","timestamp":1702227181000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-023-01397-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1397"],"URL":"https:\/\/doi.org\/10.1186\/s13244-023-01397-7","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"assertion":[{"value":"30 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study received approval from the Clinical Medical Research Ethics Committee of the First Affiliated Hospital of Anhui Medical University. The informed consent requirement was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. JL is an employee of the CT Research Center, GE Healthcare China.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}